How can you make that claim, Mr. Potter, when Ms. Bruce stated in her opening remarks that delays in the uptake of CEDAC recommendations by the drug plans was one area in which improvement was warranted?
If a problem already exists, how can you think that if the review process were accelerated, you would be better able to keep pace, when you're already having trouble doing that?